Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke

Xiangyi Kong(Capital Medical University), Yong Huo, Xiaoshu Cheng(Nanchang University), Lishun Liu(China Agricultural University), Xianhui Qin(Nanchang University), Fan Fan Hou(Southern Medical University), Yun Song(The University of Texas MD Anderson Cancer Center), Binyan Wang(Brigham and Women's Hospital), Ping Li(Nanchang University), Yan Zhang(Jilin University), Xiaobin Wang(Johns Hopkins University), Jianping Li(Nanchang University), Jingping Zhang(Central South University), Wenbin Yang(Chinese Academy of Agricultural Sciences), Richard Xu(Johns Hopkins University), Min Zhao, Benjamin Xu(Duke University), Yaren Yu(Nanfang Hospital), Xiao Huang(Tongji University), Genfu Tang(Anhui University), Shui‐Ping Zhao(Central South University)
Journal of the American College of Cardiology
May 1, 2018
10.1016/j.jacc.2018.02.072
Cited by 64

Related Papers

Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
|Thrombosis and Haemostasis|2020|334